6,544 followers
New research: Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma: There are only limited treatment options for metastatic NRAS mutant melanoma patients with resistance to immune checkpoint inhibitors.… https://t.c